A case of visceral leishmaniasis in a young American Peace Corps volunteer is reported. Both clinical and epidemiologic evidence strongly supported the diagnosis; however, hepatic and splenic aspirates for the causative organism were negative. The diagnosis was eventually confirmed through serology, employing indirect immunofluorescence and complement fixation testing of serum. The patient clinically responded dramatically to sodium stibogluconate, the drug of choice for the treatment of visceral leishmaniasis. This case is significant because it alerts the physician to an unusual cause of fever of unknown origin in residents of the Western nations and demonstrates the potential usefulness of serology in diagnosing visceral leishmaniasis when the infecting organism cannot be isolated.
A case of visceral leishmaniasis in a young American Peace Corps volunteer is reported. Both clinical and epidemiologic evidence strongly supported the diagnosis; however, hepatic and splenic aspirates for the causative organism were negative. The diagnosis was eventually confirmed through serology, employing indirect immunofluorescence and complement fixation testing of serum. The patient clinically responded dramatically to sodium stibogluconate, the drug of choice for the treatment of visceral leishmaniasis. This case is significant because it alerts the physician to an unusual cause of fever of unknown origin in residents of the Western nations and demonstrates the potential usefulness of serology in diagnosing visceral leishmaniasis when the infecting organism cannot be isolated. (9) . Although the definitive diagnosis traditionally is made by isolation of the organism from liver, spleen, or bone marrow aspirations, several studies indicate IIF testing is both sensitive and specific in diagnosing visceral leishmaniasis despite negative aspirates (4, 5, 8) . CF titers, although typically lower, also have good specificity (7) . Serology, therefore, may be particularly helpful when a sufficient amount of aspirate is difficult to obtain, when a low level of infection precludes the isolation of adequate numbers of the organism, or when the diagnostic stage is missing. This approach is also more convenient for the patient. Cross reaction between leishmaniasis and other infectious diseases, such as tuberculosis, typhus, malaria, Chagas' disease, and schistosomiasis, has been described; however, the leishmaniasis antibody levels are typically much higher, as demonstrated with this patient (4). Titers of-1:16 (tIF) or -1:8 (CF) are considered significant and may remain positive for years (1, 7) . The diagnosis may be further supported on clinical grounds. Thus, elevated IIF and CF titers with positive clinical and epidemiologic history probably are indications for treatment with antimony compounds now believed to be relatively safe (2) . Rifampin, which this patient received initially with clinical improvement, has been reported effective against cutaneous leishmaniasis; however, its efficacy against the visceral form of the disease has yet to be determined (6) .
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